Giorgio Perilongo相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease

新型 CARMIL2 功能丧失变异与儿童炎症性肠病有关

期刊:Scientific Reports

影响因子:3.8

doi:10.1038/s41598-021-85399-9

Luca Bosa, Vritika Batura, Davide Colavito, Karoline Fiedler, Paola Gaio, Conghui Guo, Qi Li, Antonio Marzollo, Claudia Mescoli, Ryusuke Nambu, Jie Pan, Giorgio Perilongo, Neil Warner, Shiqi Zhang, Daniel Kotlarz, Christoph Klein, Scott B Snapper, Thomas D Walters, Alberta Leon, Anne M Griffiths, Ma

IgG light chain

发表日期：2021

文献求助收藏

Corrigendum to "A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report" [Eur J of Canc (2017) 206-225]

对“一项欧洲随机对照试验，研究在标准长春新碱和卡铂诱导治疗的基础上添加依托泊苷，作为儿童（≤16 岁）低级别胶质瘤 18 个月治疗方案的一部分——最终报告”的更正 [Eur J of Canc (2017) 206-225]

期刊:European Journal of Cancer

影响因子:7.1

doi:10.1016/j.ejca.2017.11.017

Gnekow, Astrid K; Walker, David A; Kandels, Daniela; Picton, Susan; Giorgio Perilongo; Grill, Jacques; Stokland, Tore; Sandstrom, Per Eric; Warmuth-Metz, Monika; Pietsch, Torsten; Giangaspero, Felice; Schmidt, René; Faldum, Andreas; Kilmartin, Denise; De Paoli, Angela; De Salvo, Gian Luca

发表日期：2018

文献求助收藏

A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report

一项欧洲随机对照试验，研究在标准长春新碱和卡铂诱导治疗方案中加入依托泊苷，作为儿童（≤16岁）低级别胶质瘤18个月治疗方案的一部分——最终报告

期刊:European Journal of Cancer

影响因子:7.1

doi:10.1016/j.ejca.2017.04.019

Gnekow, Astrid K; Walker, David A; Kandels, Daniela; Picton, Susan; Giorgio Perilongo; Grill, Jacques; Stokland, Tore; Sandstrom, Per Eric; Warmuth-Metz, Monika; Pietsch, Torsten; Giangaspero, Felice; Schmidt, René; Faldum, Andreas; Kilmartin, Denise; De Paoli, Angela; De Salvo, Gian Luca

发表日期：2017

文献求助收藏